Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis
Open Access
- 21 May 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 30 (2), 139-151
- https://doi.org/10.1093/eurheartj/ehn538
Abstract
The study of biomarkers and their signalling pathways has allowed the development of new therapeutic strategies in a range of disorders. The aim of the present systematic review is to provide an overview of different biomarkers in patients with hypertrophic cardiomyopathy that could give some insight into the pathophysiologic mechanism(s) underlying the typical clinical and histological manifestations of the disease. Several pathophysiological models are presented and discussed, including studies that have investigated these biomarkers for diagnostic and prognostic reasons, in relation to disease progression and/or mortality.Keywords
This publication has 122 references indexed in Scilit:
- Significance of Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide on Left Ventricular Remodeling in Non-Obstructive Hypertrophic Cardiomyopathy Attributable to the Asp175Asn Mutation in the α-Tropomyosin GeneThe American Journal of Cardiology, 2008
- Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Plasma amino-terminal pro–B-type natriuretic peptide quantification in hypertrophic cardiomyopathyAmerican Heart Journal, 2005
- Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 2004
- Plasma atrial natriuretic peptide is elevated in patients with hypertrophic cardiomyopathyInternational Journal of Cardiology, 1996
- Endothelin-1 and Its Receptor in Hypertrophic CardiomyopathyHypertension, 1996
- Increased production of endothelin‐1 in the hypertrophied rat heart due to pressure overloadFEBS Letters, 1993
- Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarctionThe Lancet, 1993
- Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis.Stroke, 1984
- Myocardial Ultrastructure in Idiopathic Hypertrophic Subaortic StenosisCirculation, 1972